Scholar Rock Holding Corp (SRRK)
7.42
+0.35
(+4.95%)
USD |
NASDAQ |
Oct 04, 16:00
7.41
-0.01
(-0.13%)
After-Hours: 20:00
Scholar Rock Research and Development Expense (Annual): 121.90M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 121.90M |
| December 31, 2022 | 124.44M |
| December 31, 2021 | 108.47M |
| December 31, 2020 | 74.06M |
| Date | Value |
|---|---|
| December 31, 2019 | 54.22M |
| December 31, 2018 | 36.31M |
| December 31, 2017 | 19.94M |
| December 31, 2016 | 12.48M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
54.22M
Minimum
2019
124.44M
Maximum
2022
96.62M
Average
108.47M
Median
2021
Research and Development Expense (Annual) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |
| Theriva Biologics Inc | 14.31M |
| Oragenics Inc | 15.49M |